# PRODUCTION OF A CGMP BATCH OF TRIAPINE INJECTION

> **NIH NIH N02** · IRISYS, INC. · 2021 · $249,951

## Abstract

The aim of the contract to manufacture Drug Product (Novobiocin is Capsule  and Triapine is Injectable)

## Key facts

- **NIH application ID:** 10492159
- **Project number:** 75N98019D00058-0-759102100062-1
- **Recipient organization:** IRISYS, INC.
- **Principal Investigator:** MIRAY MOUSA
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $249,951
- **Award type:** —
- **Project period:** 2021-02-22 → 2024-02-21

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10492159

## Citation

> US National Institutes of Health, RePORTER application 10492159, PRODUCTION OF A CGMP BATCH OF TRIAPINE INJECTION (75N98019D00058-0-759102100062-1). Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/grant/nih/10492159. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*